| editorial | Q871232 |
| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1106387016 |
| P356 | DOI | 10.1186/S12933-018-0766-0 |
| P932 | PMC publication ID | 6112138 |
| P698 | PubMed publication ID | 30153832 |
| P50 | author | Enrique Z Fisman | Q42334794 |
| P2093 | author name string | Alexander Tenenbaum | |
| P2860 | cites work | Elevated Triglyceride Level Is Independently Associated With Increased All-Cause Mortality in Patients With Established Coronary Heart Disease: Twenty-Two-Year Follow-Up of the Bezafibrate Infarction Prevention Study and Registry. | Q39936875 |
| Associations of Omega-3 Fatty Acid Supplement Use With Cardiovascular Disease Risks: Meta-analysis of 10 Trials Involving 77 917 Individuals | Q48517326 | ||
| Efficacy and Safety of Adding Omega-3 Fatty Acids in Statin-treated Patients with Residual Hypertriglyceridemia: ROMANTIC (Rosuvastatin-OMAcor iN residual hyperTrIglyCeridemia), a Randomized, Double-blind, and Placebo-controlled Trial | Q49977664 | ||
| Effects of n-3 fatty acids and exercise on oxidative stress parameters in type 2 diabetic: a randomized clinical trial. | Q55194336 | ||
| Omega-3 polyunsaturated fatty acids favourably modulate cardiometabolic biomarkers in type 2 diabetes: a meta-analysis and meta-regression of randomized controlled trials. | Q55510348 | ||
| Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease | Q55919856 | ||
| Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease | Q28215274 | ||
| Treatment with high-dose n-3 PUFAs has no effect on platelet function, coagulation, metabolic status or inflammation in patients with atherosclerosis and type 2 diabetes | Q33564624 | ||
| Effect of n-3 Polyunsaturated Fatty Acid Supplementation on Metabolic and Inflammatory Biomarkers in Type 2 Diabetes Mellitus Patients | Q33851933 | ||
| Omega-3 fatty acid supplementation and cardiovascular disease | Q36387184 | ||
| Fish oil -- how does it reduce plasma triglycerides? | Q36584568 | ||
| Hepatic insulin resistance both in prediabetic and diabetic patients determines postprandial lipoprotein metabolism: from the CORDIOPREV study | Q36815362 | ||
| Omega-3 fatty acids and coronary heart disease risk: clinical and mechanistic perspectives | Q37045298 | ||
| Atherogenic dyslipidemia and risk of silent coronary artery disease in asymptomatic patients with type 2 diabetes: a cross-sectional study. | Q37119482 | ||
| Effects of 6-month eicosapentaenoic acid treatment on postprandial hyperglycemia, hyperlipidemia, insulin secretion ability, and concomitant endothelial dysfunction among newly-diagnosed impaired glucose metabolism patients with coronary artery dise | Q37211911 | ||
| Cholesterol remnants and triglycerides are associated with decreased myocardial function in patients with type 2 diabetes | Q37278695 | ||
| Mechanisms underlying the cardioprotective effects of omega-3 polyunsaturated fatty acids | Q37728565 | ||
| Eicosapentaenoic and Docosahexaenoic Acids Attenuate Progression of Albuminuria in Patients With Type 2 Diabetes Mellitus and Coronary Artery Disease | Q38373937 | ||
| TRIGLYCERIDES, ATHEROSCLEROSIS, AND CARDIOVASCULAR OUTCOME STUDIES: FOCUS ON OMEGA-3 FATTY ACIDS. | Q39000699 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | cardiovascular disease | Q389735 |
| P304 | page(s) | 119 | |
| P577 | publication date | 2018-08-28 | |
| P1433 | published in | Cardiovascular Diabetology | Q2468083 |
| P1476 | title | Omega-3 polyunsaturated fatty acids supplementation in patients with diabetes and cardiovascular disease risk: does dose really matter? | |
| P478 | volume | 17 |
Search more.